INH154 is a potent inhibitor of Nek2 and Hec1 binding. NH154 binds to Hec1, thus blocking Hec1 phosphorylation by NEK2, and kills cancer cells at the nanomolar range.
[1] Yanfen Fang, Xiongwen Zhang. Cell Cycle. 2016;15(7):895-907.
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 1mg | ¥540.00 | 现货 | 1 | |
| 5mg | ¥1,350.00 | 现货 | 1 | |
| 10mg | ¥2,070.00 | 现货 | 1 | |
| 25mg | ¥3,780.00 | 现货 | 1 | |
| 10mM (in 1mL DMSO) | ¥1,166.00 | 现货 | 1 |
















INH154 is a potent inhibitor of Nek2 and Hec1 binding. NH154 binds to Hec1, thus blocking Hec1 phosphorylation by NEK2, and kills cancer cells at the nanomolar range.
[1] Yanfen Fang, Xiongwen Zhang. Cell Cycle. 2016;15(7):895-907.
Animal experiment: | Mice[1]Human triple negative breast cancer MDA-MB-468 cells, which expressed high levels of both Hec1 and Nek2, are used to test the efficacy of tumor growth in mouse xenograft. While tumor volumes reach ~100mm3, mice are randomly divided into 5 treatment groups and began to receive thrice-weekly intraperitoneal (i.p.) injections of vehicle control, 10 mg/kg INH41, 50 mg/kg INH41, 5 mg/kg INH154 or 20 mg/kg INH154. Treatment is continued for 6.5 weeks and the tumor sizes were measured[1]. |
References: [1]. Hu CM, et al. Novel small molecules disrupting Hec1/Nek2 interaction ablate tumor progression by triggering Nek2 degradation through a death-trap mechanism. Oncogene. 2015 Mar 5;34(10):1220-30. |